Revenue
30.3 million EUR
2020 · EUR
Exact inputs and evidence
- Revenue: 30346000 EUR Source
Market value is not computed: this company’s US price is per depositary share, not per ordinary share.
375 filing records in this dataset, filed from 2018-01-12 to 2022-03-10. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 2004-06-14 to 2026-11-20; this is not a statement that none were filed.
16546000 EUR
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2022-03-10.
Financial data available through: 2020-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
EUR 31.27 million
–
Current period
EUR 30.35 million
–
30346000 − 31265000 = -919000 EUR
31265000 EUR · 2019-01-01 – 2019-12-31
Inspect prior input Prior source30346000 EUR · 2020-01-01 – 2020-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−EUR 7.64 million
–
Current period
−EUR 10.87 million
–
-10868000 − -7644000 = -3224000 EUR
-7644000 EUR · 2019-01-01 – 2019-12-31
Inspect prior input Prior source-10868000 EUR · 2020-01-01 – 2020-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−EUR 32.89 million
–
Current period
−EUR 2.85 million
–
-2849000 − -32894000 = 30045000 EUR
-32894000 EUR · 2019-01-01 – 2019-12-31
Inspect prior input Prior source-2849000 EUR · 2020-01-01 – 2020-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | 4138000 | 14369000 Derived | -10231000 | 974000 Derived | -11205000 | Unavailable | Source
|
| 2016 2016-01-01 – 2016-12-31 | 6130000 | 17909000 Derived | -11779000 | -1047000 Derived | -10732000 | Unavailable | Source
|
| 2017 2017-01-01 – 2017-12-31 | 12025000 | 25959000 Derived | -13934000 | 1314000 Derived | -15248000 | Unavailable | Source
|
| 2018 2018-01-01 – 2018-12-31 | 21107000 | 39585000 Derived | -18478000 | -8898000 Derived | -9580000 | Unavailable | Source
|
| 2019 2019-01-01 – 2019-12-31 | 31265000 | 54642000 Derived | -23377000 | -15733000 Derived | -7644000 | Unavailable | Source
|
| 2020 2020-01-01 – 2020-12-31 | 30346000 | 37957000 Derived | -7611000 | 3257000 Derived | -10868000 | Unavailable | Source
|
Amounts are exact, in EUR.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(EUR) | Source evidence |
|---|---|---|---|
| 2015 | Revenue | 4138000 |
|
| 2016 | Revenue | 6130000 |
|
| 2017 | Revenue | 12025000 |
|
| 2018 | Revenue | 21107000 |
|
| 2019 | Revenue | 31265000 |
|
| 2020 | Revenue | 30346000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Year over year | No prior comparable period |
|
| 2016 | Year over year | 48.1% |
|
| 2017 | Year over year | 96.2% |
|
| 2018 | Year over year | 75.5% |
|
| 2019 | Year over year | 48.1% |
|
| 2020 | Year over year | -2.9% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Operating margin | -247.2% |
|
| 2016 | Operating margin | -192.2% |
|
| 2017 | Operating margin | -115.9% |
|
| 2018 | Operating margin | -87.5% |
|
| 2019 | Operating margin | -74.8% |
|
| 2020 | Operating margin | -25.1% |
|
| 2015 | Net margin | -270.8% |
|
| 2016 | Net margin | -175.1% |
|
| 2017 | Net margin | -126.8% |
|
| 2018 | Net margin | -45.4% |
|
| 2019 | Net margin | -24.4% |
|
| 2020 | Net margin | -35.8% |
|
| 2015 | Free cash flow margin | Not reported |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(EUR) | Source evidence |
|---|---|---|---|
| 2015 | Operating cash flow | -9655000 |
|
| 2016 | Operating cash flow | -10259000 |
|
| 2017 | Operating cash flow | -13119000 |
|
| 2018 | Operating cash flow | -13434000 |
|
| 2019 | Operating cash flow | -32894000 |
|
| 2020 | Operating cash flow | -2849000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(EUR) | Source evidence |
|---|---|---|---|
| 2015 | Free cash flow | Unavailable |
|
| 2016 | Free cash flow | Unavailable |
|
| 2017 | Free cash flow | Unavailable |
|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2016 | Liabilities / assets | 18.6% |
|
| 2017 | Liabilities / assets | 20.7% |
|
| 2018-12-31 | Liabilities / assets | Not reported |
|
| 2019-12-31 | Liabilities / assets | Not reported |
|
| 2020-12-31 | Liabilities / assets | Not reported |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2016 | Current assets / current liabilities | 9.06× |
|
| 2017 | Current assets / current liabilities | 4.49× |
|
| 2018 | Current assets / current liabilities | 3.55× |
|
| 2019 | Current assets / current liabilities | 1.94× |
|
| 2020 | Current assets / current liabilities | 3.15× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | −EUR 11.21 million Exact valueExact value: -11205000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | −EUR 9.66 million Exact valueExact value: -9655000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2016 2016-01-01 – 2016-12-31 | −EUR 10.73 million Exact valueExact value: -10732000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | −EUR 10.26 million Exact valueExact value: -10259000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | −EUR 15.25 million Exact valueExact value: -15248000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | −EUR 13.12 million Exact valueExact value: -13119000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2018-01-01 – 2018-12-31 | −EUR 9.58 million Exact valueExact value: -9580000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | −EUR 13.43 million Exact valueExact value: -13434000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −EUR 7.64 million Exact valueExact value: -7644000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | −EUR 32.89 million Exact valueExact value: -32894000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −EUR 10.87 million Exact valueExact value: -10868000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | −EUR 2.85 million Exact valueExact value: -2849000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
375 filings · 400 latest values · 400 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001712641, 1712641, BFRA, edgar:1712641
Also known as Biofrontera AG